v3.26.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (9,158,734) $ (5,861,335)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of Deferred Grant Reimbursement (52,913) (54,359)
Depreciation of property and equipment 287,961 267,382
Non-cash lease expense 53,367 34,955
Stock-based compensation 1,988,105 1,125,639
Change in fair value of SAFE 8
Changes in operating assets and liabilities:    
Grants receivable 219,923 145,037
Prepaid expenses and other current assets (19,096) (99,028)
Tax receivable (105,205)
Accounts payable and accrued expenses 311,085 221,340
Due to related party (26,533) (4,243,022)
Tax payable (42,267)
Net cash (used in) operating activities (6,502,040) (8,505,650)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Deferred grant reimbursement 19,699 37,235
Purchases of property and equipment (169,917) (396,451)
Net cash (used in) investing activities (150,218) (359,216)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Issuance of common shares 14,528,964
Related Party Note 3,976,860
Issuance of Warrants for Private placement 11,819
Payments on finance lease obligations (27,709)
Net cash provided by (used in) financing activities (27,709) 18,517,643
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS (6,679,967) 9,652,777
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR 9,719,310 66,533
CASH AND CASH EQUIVALENTS - END OF YEAR 3,039,343 9,719,310
Supplemental disclosures of cash flow information:    
Interest Expense 6,252
Income Taxes
Non-cash investing and financing activities:    
Conversion of SAFE Note to common shares 1,000,008
Related party debt forgiveness 147,103
Right-of-use assets obtained in exchange for new lease liabilities $ 136,391